Sign Out
Hypersensitivity to the active substances or to any of the excipients listed in Description or hypersensitivity to a previous dose of Qdenga.
Individuals with congenital or acquired immune deficiency, including those receiving immunosuppressive therapies such as high doses of systemic corticosteroids (e.g. 20 mg/day or 2 mg/kg body weight/day of prednisone for 2 weeks or more) within 4 weeks prior to vaccination, or any other medicinal product with known immunosuppressive properties including chemotherapy. The time to avoid vaccination after immunosuppressive treatment should be considered on an individual basis.
Individuals with symptomatic HIV infection or with asymptomatic HIV infection when accompanied by evidence of impaired immune function.
Pregnant women (see Use in Pregnancy & Lactation).
Breast-feeding women (see Use in Pregnancy & Lactation).
Continue with Google